Wysham is an Endocrine Today Editorial Board Member, 2021-2022 president of the Endocrine Society and a clinical professor of medicine at the University of Washington.
Adults with type 2 diabetes assigned tirzepatide alongside insulin glargine had greater reductions in HbA1c and body weight compared with placebo, according to data from the SURPASS trial program.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.
